NCT00179530

Brief Summary

To evaluate whether a 5-week relaxation response intervention influences the learning, memory or attention of healthy older adults.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for phase_2 healthy

Timeline
Completed

Started May 1999

Longer than P75 for phase_2 healthy

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 1999

Completed
6.4 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2007

Completed
Last Updated

November 5, 2007

Status Verified

November 1, 2007

First QC Date

September 13, 2005

Last Update Submit

November 2, 2007

Conditions

Healthy

Outcome Measures

Primary Outcomes (1)

  • Evaluate whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance in healthy older adults.

    8 weeks

Secondary Outcomes (1)

  • Evaluate whether a RR training program would decrease salivary cortisol levels in healthy older adults.

    8 weeks

Interventions

Relaxation ResponseBEHAVIORAL

Relaxation training

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • to 80 years od age
  • No prior or current psychiatric or neurological condition.
  • score above 24 on the Mini-Mental State Exam (MMSE)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Jeffery A Dusek, PhD

    Beth Israel Deaconess Medical Center, Mind/Body Medical Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 16, 2005

Study Start

May 1, 1999

Study Completion

September 1, 2007

Last Updated

November 5, 2007

Record last verified: 2007-11